AI Insight: Prestige Consumer Healthcare’s current price of $52.41 is substantially below all valuation metrics, indicating significant undervaluation with potential upside exceeding 4400%. High valuation variability and low growth score imply notable risk, though liquidity and leverage metrics are strong. Monte Carlo analysis shows minimal downside below current price, reinforcing asymmetric risk-return profile.